A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation

Bone Marrow Transplant. 2014 Aug;49(8):1113-5. doi: 10.1038/bmt.2014.94. Epub 2014 May 5.

Authors

K Maie¹, S Fuji², K Tajima², M Tatsuno², S Yamagata², N Takahashi², R Ueda², H Hashimoto², K Takano², Y Inoue², A Ito², Y Hayashi², K Okinaka², S Kurosawa², S-W Kim², R Tanosaki³, Y Heike², T Yamashita², T Fukuda²

Affiliations

¹ 1] Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan [2] Department of Hematology, University of Tsukuba, Tsukuba, Japan.
² Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
³ Department of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan.

PMID: 24797181
DOI: 10.1038/bmt.2014.94

No abstract available

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Age Factors
Aged
Allografts
Antigens, CD34*
Female
Hematologic Neoplasms / mortality
Hematologic Neoplasms / therapy*
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation*
Retrospective Studies
Transplantation Conditioning*

Substances

Antigens, CD34